Sector: health
Conviction from: NASDAQS&P
52-week range: 43.2072.88
Bio-Techne supplies proteins, antibodies, reagents, and instruments for life-science research and molecular and cell-based diagnostics.
6 tracked filer(s) hold this · 2 opened, 0 added, 3 trimmed in 30-SEP-2026
Aggregate 13FScore 61 — mean of 6 scored holder(s) · buyers (new/add) avg 58. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Ancora | 42 | New buy | 46 | $3,334 | 0.0% |
| Steve Cohen / Point72 | 75 | New buy | 69,524 | $5,038,404 | 0.0% |
| Ruane Cunniff / Sequoia Fund | 77 | Holds (flat) | 3,342,837 | $242,255,397 | 3.9% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -4% | 907,849 | $65,791,817 | 0.1% |
| Larry Robbins / Glenview | 61 | Trimmed -39% | 35,839 | $2,597,252 | 0.0% |
| Louis Bacon / Moore | 52 | Trimmed -74% | 32,500 | $2,355,275 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
6 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-04-08 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2026-03-26 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2026-02-24 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2026-01-28 | April McClain Delaney MD06 | SELL | $1,001 - $15,000 | PTR |
| 2025-12-05 | April McClain Delaney MD06 | BUY | $1,001 - $15,000 | PTR |
| 2025-12-02 | April McClain Delaney MD06 | BUY | $1,001 - $15,000 | PTR |
2 disclosed trade(s) by 1 filer(s).
| Report | Date | Stance |
|---|
| #97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami | 2025-05-28 | WATCH |